about
TMEM59 defines a novel ATG16L1-binding motif that promotes local activation of LC3The genome of a pathogenic rhodococcus: cooptive virulence underpinned by key gene acquisitionsThe MurC ligase essential for peptidoglycan biosynthesis is regulated by the serine/threonine protein kinase PknA in Corynebacterium glutamicumEvolution of the Rhodococcus equi vap pathogenicity island seen through comparison of host-associated vapA and vapB virulence plasmids.Characterization of HMW-PBPs from the rod-shaped actinomycete Corynebacterium glutamicum: peptidoglycan synthesis in cells lacking actin-like cytoskeletal structures.Analysis of genes involved in arsenic resistance in Corynebacterium glutamicum ATCC 13032Phosphorylation of a novel cytoskeletal protein (RsmP) regulates rod-shaped morphology in Corynebacterium glutamicum.Arsenate reductase, mycothiol, and mycoredoxin concert thiol/disulfide exchangeBH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α.Cytoskeletal proteins of actinobacteria.Altered morphology produced by ftsZ expression in Corynebacterium glutamicum ATCC 13869.The Arsenic Detoxification System in Corynebacteria: Basis and Application for Bioremediation and Redox Control.Characterization and use of catabolite-repressed promoters from gluconate genes in Corynebacterium glutamicum.Retention of inorganic arsenic by coryneform mutant strains.DivIVA uses an N-terminal conserved region and two coiled-coil domains to localize and sustain the polar growth in Corynebacterium glutamicum.Identification of the emerging skin pathogen Corynebacterium amycolatum using PCR-amplification of the essential divIVA gene as a target.Intracellular Staphylococcus aureus Modulates Host Central Carbon Metabolism To Activate AutophagyMorphological changes and proteome response of Corynebacterium glutamicum to a partial depletion of FtsIRepetitive Exposure of IL-17 Into the Murine Air Pouch Favors the Recruitment of Inflammatory Monocytes and the Release of IL-16 and TREM-1 in the Inflammatory FluidsHost-directed kinase inhibitors act as novel therapies against intracellular Staphylococcus aureusA Novel Screening Strategy Reveals ROS-Generating Antimicrobials That Act Synergistically against the Intracellular Veterinary Pathogen Rhodococcus equiThe extracellular thioredoxin Etrx3 is required for macrophage infection in Rhodococcus equiAcetaminophen cytotoxicity in HepG2 cells is associated with a decoupling of glycolysis from the TCA cycle, loss of NADPH production, and suppression of anabolismIdentification of novel targets for host-directed therapeutics against intracellular Staphylococcus aureusMycoredoxins Are Required for Redox Homeostasis and Intracellular Survival in the Actinobacterial Pathogen Rhodococcus equiHost-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureusIntracellular Staphylococcus aureus Elicits the Production of Host Very Long-Chain Saturated Fatty Acids with Antimicrobial ActivityOxidative Stress-Generating Antimicrobials, a Novel Strategy to Overcome Antibacterial Resistance
P50
Q24313405-90A7EC2D-EE34-470C-909B-551D965FEFD7Q28749079-D363C95C-4D34-4593-B004-7C445A4CA213Q28854136-30767060-2A90-4A92-B2BA-804E444E9DFBQ31161840-9543BD4F-B40D-44FF-8140-3D3A5AA664E9Q33299372-2079FBA8-070A-4B00-B94A-20A6222F4F4BQ34098007-69F29A47-6317-4E6E-B6F8-205EAB7A620CQ34121598-6B57B246-1758-45F7-A535-A5764A47881BQ34962642-4D08F7F0-6ADA-43CF-9493-5741E46292C4Q36000128-E96D7353-3E44-421A-B90A-F3D7264C525FQ38000559-0AD2093B-6E61-4531-8AD5-7038AA4E7E0EQ40399928-996C57CE-5D08-48AA-A25C-66D9FF3AA021Q41931534-6FFA8AB7-B1F3-430E-92E4-918A4A7CFD0FQ43182308-41ECAC97-22C6-4F71-9FA9-AAC8B9D0A678Q51925724-659A700A-5DE1-4BFD-AAEB-F8E0C69A6271Q53387589-9103D9F0-9CF9-450F-9593-DE8F4790C713Q54568709-5229694F-9920-4AA5-8DE5-4298B6B11A76Q57995180-7A793231-1800-4BA3-A2B5-A011230197B1Q57995350-77593207-F6A6-4108-A52F-5D5579A01052Q59798733-8687615D-CFB8-4011-A56F-D6EAF4D06D67Q64077868-810D1A15-DD6C-4454-858F-1A742704AEEEQ89510071-1B817CE3-13AE-4B81-85D2-043B8CC9ADCBQ90195012-384030C6-0E53-49D3-B45B-A8A483CF86FCQ90528095-CF746B16-7255-48AB-806F-A5AB2CE854ACQ90975080-EB9133A1-9970-4950-B9EB-12081B98835AQ91299519-EA4A6791-C7A4-45C4-ADB0-F0C272E2D847Q91643179-901AE759-15B6-4229-B02D-31E5E7D7EF84Q92081857-737AF688-663A-4DC8-9E3B-29B368F88C99Q94480167-F42639A5-303B-46D4-8BF0-CE848B859267
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michal Letek
@ast
Michal Letek
@en
Michal Letek
@es
Michal Letek
@nl
Michal Letek
@sl
type
label
Michal Letek
@ast
Michal Letek
@en
Michal Letek
@es
Michal Letek
@nl
Michal Letek
@sl
prefLabel
Michal Letek
@ast
Michal Letek
@en
Michal Letek
@es
Michal Letek
@nl
Michal Letek
@sl
P106
P1153
8870071200
P31
P496
0000-0002-9509-5174